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Abstract: Early-onset obesity is known to culminate in type 2 diabetes, arterial hypertension and 
subsequent cardiovascular disease. The role of sodium (Na+) homeostasis in this process is 
incompletely understood, yet correlations between Na+ accumulation and hypertension have been 
observed in adults. We aimed to investigate these associations in adolescents. A cohort of 32 
adolescents (13–17 years), comprising 20 obese patients, of whom 11 were hypertensive, as well as 
12 age-matched controls, underwent 23Na-MRI of the left lower leg with a standard clinical 3T 
scanner. Median triceps surae muscle Na+ content in hypertensive obese (11.95 mmol/L 
[interquartile range 11.62–13.66]) was significantly lower than in normotensive obese (13.63 
mmol/L [12.97–17.64]; p = 0.043) or controls (15.37 mmol/L [14.12–16.08]; p = 0.012). No significant 
differences were found between normotensive obese and controls. Skin Na+ content in 
hypertensive obese (13.33 mmol/L [11.53–14.22] did not differ to normotensive obese (14.12 
mmol/L [13.15–15.83]) or controls (11.48 mmol/L [10.48–12.80]), whereas normotensive obese had 
higher values compared to controls (p = 0.004). Arterial hypertension in obese adolescents is 
associated with low muscle Na+ content. These findings suggest an early dysregulation of Na+ 
homeostasis in cardiometabolic disease. Further research is needed to determine whether this 
association is causal and how it evolves in the transition to adulthood. 
Keywords: obesity, sodium, hypertension, adolescents, MRI, MR-spectroscopy 
 
1. Introduction 
Since the 1980s, the prevalence of obesity in many countries has doubled, affecting an estimated 
603.7 million adults and 107.7 million children [1]. Globally, four million deaths per year have been 
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attributed to increased body mass index (BMI), often due to associated cardiovascular disease (CVD) 
[1]. It is assumed that the course for the development of CVD is already set in childhood, but the 
exact mechanisms have remained unknown [1]. Amongst others, there are indications for chronic 
over-activity of the sympathetic nervous system and the renin–angiotensin–aldosterone system 
(RAAS) [2], as well as obesity-driven low-grade systemic inflammation-promoting type 2 diabetes 
[3]. 
Nutrition is known to play an important role in the pathogenesis of obesity, and mineral 
sodium (Na+) has been discussed as an essential risk factor for CVD. Many factors may mediate the 
ability of high salt intake to increase blood pressure, however, their relative contributions to the 
pathogenesis of salt-induced hypertension are controversial [4,5]. Although several studies report 
deleterious effects, including a rise in blood pressure and the emergence of chronic kidney disease, 
some other studies have found more neutral effects [4]. Nevertheless, the rate of deaths from 
cardiovascular causes has been attributed to sodium consumption, and was found to be lower in 
regions and cultures with reduced salt intake [5]. In overweight adults, sodium-induced increases in 
circulating volume and hypertension have been described, which can elevate mortality by 
promoting left ventricular hypertrophy, altering vascular resistance and ultimately leading to heart 
failure [6]. 
Intake and accrual of Na+ over the life course may, therefore, be an important determinant of 
CVD risk. Measurement of Na+ status is routinely done by analysis of spot or 24 h urines. However, 
doubts have been raised about the suitability of 24 h urinary Na+ excretion for estimating exact salt 
intake [7]. Whether urinary Na+ excretion is at all reflecting tissue Na+ content is currently unknown. 
In recent studies, 23Na-magnetic resonance imaging (MRI) has been introduced as a reliable, 
non-invasive method to quantify Na+ tissue content [8–13] that overcomes this limitation. It has been 
suggested that tissue Na+ accumulation with ageing could be implicated in the pathogenesis of 
refractory hypertension in adults [9]. However, these studies were of adult patients with advanced 
disease, where the independent effects of ageing, as well as hypertension and diet-related obesity, 
were difficult to separate. Only little is known about Na+ storage in children and adolescents. 
However, studies in younger populations would have the advantage of excluding the effects of 
advanced ageing or long-established disease. To overcome this knowledge gap, the study 
investigates the associations between Na+ storage, hypertension and obesity in adolescent patients. 
2. Materials and Methods 
In this cross-sectional study twenty, previously untreated obese (aged 13–17 [median 14] years) 
and twelve normal-weight “control” (aged 13–16 [median 15] years) adolescents were studied. 
Obese and control subjects were matched for sex and age. Obese patients were recruited 
prospectively from the social–paediatric centre (Charité–Universitätsmedizin Berlin) between 2014 
and 2017, and they were further divided into two sub-groups, according to their blood pressure 
status. They were defined as obese if their body mass index (BMI) exceeded the 97th Kromeyer–
Hauschild percentile according to sex and age [14]. Controls were patients undergoing routine 
clinical diagnostic MRI for non-cardiac and non-endocrinologic reasons that volunteered to have our 
23Na-MRI protocol added. The primary outcome was the absolute muscle sodium content; the 
secondary outcome was skin sodium content. Subjects with implanted devices not compatible with 
MRI and those with claustrophobia were excluded. Written informed consent from participants or 
their legal guardians was obtained before enrolment. The study was approved by the institutional 
ethics review board of the Charité–Universitaetsmedizin Berlin (approval reference number 
EA2/036/14) and conducted according to the principles of the Declaration of Helsinki. 
Additionally to known blood pressure status, at the time of MRI, the subjects were comfortably 
seated with back support for at least five minutes while arterial blood pressure was measured on the 
right upper arm using an oscillometric Dinamap pro-100 device (Critikon, Milwaukee, USA). Cuff 
size was chosen appropriately to arm circumference. As there is still no single value threshold 
available in obese and overweight children (BMI >85th percentile) and even adult guideline values 
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vary between ACC and ESC guidelines [14–16], in this study, hypertension was defined if systolic 
and/or diastolic values exceeded age-, gender- and height-specific (95th) [16] reference percentiles. 
Anthropometric data were acquired using standardised clinical protocols and participants 
completed a questionnaire about salt intake, answering on a scale of 1–10 according to their 
agreement with the question asked. An oral glucose-tolerance test (OGTT) was performed and 
HbA1c, fasten insulin and glucose were measured. Homeostatic model assessment (HOMA) indices 
above 2.0 were considered hyperinsulinism. 
All subjects rested for at least 15 min before their left calf was scanned at its widest 
circumference. Imaging was performed on a Philips Ingenia 3.0 Tesla MR scanner (Ingenia R 5.4, 
Philips Healthcare, Best, The Netherlands) with a 23Na send/receive knee-coil (Rapid Biomedical, 
Rimpar, Germany), following previously validated methods, using a 2D-spoiled gradient echo 
sequence (total acquisition time, TA = 20.5 min; echo time, TE = 2.138 ms; repetition time, TR = 100 
ms; flip angle, FA = 90°; 196 averages, resolution: 3 × 3 × 30 mm3) [9,10]. Four calibration phantoms 
containing aqueous solutions of 10, 20, 30, and 40 mmol/L NaCl were scanned as reference 
standards, together with the subject’s calf. Simultaneously, tissue water content was measured by 
1H-MRI, using a fat-saturated inversion-prepared SE sequence (inversion time, TI = 210 ms; TA = 6.27 
min; TE = 12 ms; TR = 3000 ms; FA = 90°; 1 average, resolution: 1.5 × 1.5 × 5 mm3), as implemented by 
other investigators [11]. 
Using ImageJ (NIH, version 1.50i) and the anatomical image (T1-weighted spoiled gradient 
echo sequence) as guidance, regions of interest (ROI) were drawn as centrally as possible whilst 
excluding prominent vascular structures, which are rich in Na+. Relevant ROIs included the total leg, 
triceps surae muscle, as the largest muscle of the calf (with medial and lateral gastrocnemius and 
soleus; referred in the text as “muscle”), skin, tibial bone and subcutaneous fat. Muscle ROIs and 
subcutaneous ROIs were marked on the T1-weighted sequence, while skin ROI, total leg ROI and 
phantom ROIs were drawn on the Na+ image, as already described by other authors [11]. ROI areas 
were assessed through each ROI’s voxel count and measured in arbitrary units (AU). 
The signal intensity of each ROI was measured and linear trend analysis was used to translate 
this intensity to a NaCl concentration, according to the calibration phantoms’ predefined contents of 
10, 20, 30, and 40 mmol/L [17]. A calibration standard for tissue water was based on the water 
content of the 10 mmol/L NaCl tube. Previous studies have suggested 1H-MRI as a means to 
non-invasively assess tissue water content changes, based on a linear relationship between 1H-MRI 
measurements and actual water content [9]. Thus, the combination of water and Na+ measurements 
allows the differentiation of a water-dependent Na+ storage (e.g., oedema) from water-independent 
Na+ storage (e.g., bound to glycosaminoglycans) [18]. 
Since fat tissue is rather low in Na+ content, we assessed whether decreased Na+ content in 
muscle might be due to increased muscle fat accumulation. Muscle fat content was assessed by the 
ratio of fat-voxels and the total number of voxels within the muscle. As described by Kopp et al., 
1H-T1-weighted tissue signal intensities greater than 30% above the intensity level of the phantom 
tubes were defined “fat-voxels” [19]. The ratio of fat-voxels and the total number of voxels within 
the muscle was used to assess fatty muscle degeneration. 
Data are expressed as median and interquartile range (Q1–Q3) unless otherwise stated. Data 
were tested for normality using the Shapiro–Wilk and Shapiro–Francia tests. Data were analysed for 
stochastic dominance among the three groups by applying a non-parametric Kruskal–Wallis test, 
followed by a Bonferroni-corrected Dunn’s test as a nonparametric, pairwise, multiple comparison 
procedure. Pearson’s chi-square test was used with Fisher’s exact test for comparison of categorical 
variables. To plot the combined effects of BMI and hypertension on Na+ content in muscle, predictive 
margins were calculated and plotted. Correlations were assessed by non-parametric multivariate 
regression analysis. Multifactorial effects (and their 95% confidence interval, CI) were assessed using 
robust regression. Significance level was set at p = 0.05 and 95% confidence intervals were calculated. 
Inter-observer variability was evaluated for Na+ measurements of 25 different subjects using a 
Bland–Altman plot. Stata (Version 15.1, StataCorp, College Station, Texas, USA) was used for 
statistical analysis. 
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3. Results 
Na+ content and tissue water content was analysed in a total of 32 subjects, of which 11 were 
hypertensive obese patients, nine normotensive obese patients and 12 normal-weight controls. The 
characteristics of these three groups are shown in Table 1. Age and sex did not significantly differ 
between groups, and BMI did not differ between both obesity groups (Figure 1a). Heart rate, systolic 
and diastolic blood pressure did not differ between normotensive obese and controls, but did 
between those two groups and hypertensive obese (Figure 1b, 1c and 1d, respectively). Only one 
patient had isolated diastolic blood pressure values exceeding the 95th percentile. All remaining 
hypertensive patients had systolic hypertension. 
Table 1. Baseline characteristics. Median (interquartile range), unless stated otherwise. 
Subjects 
 
 
Controls 
(n = 12) 
Normoten–
sive obese (n 
= 9) 
Hyperten–
sive obese 
(n = 11) 
p value 
normotensive 
obese vs. 
controls 
p value 
hypertensive 
obese vs. 
controls 
p value 
hypertensive 
obese vs. 
normotensive 
obese 
p value 
overall 
Age [years] 
15 (14–
16) 
15 (14–16) 14 (13–14) 1.000 0.088 0.060 0.072 
Male Gender (n) 4 (33%) 4 (44%) 5 (45%)    0.808 
Cross-Sectional Total 
Leg Area (mm2) 
3830 
(3536–
4387) 
6862 (5917–
7244) 
5912 (5217–
6369) <0.001 0.0007 0.533 <0.001 
Tibial Bone Area 
(mm2) 
229 (208–
244) 311 (245–322) 
284 (225–
317) 0.011 0.117 0.478 0.022 
Total muscle area 
(mm2) 
2265 
(1989–
2482) 
3196 (2780–
3565) 
2960 (2750–
3377) 0.002 0.003 1.000 0.001 
Subcutaneous Fat 
Area (mm2) 
1084 
(950–
1363) 
2526 (2078–
3787) 
2128 (1824–
2939) <0.001 0.001 0.758 <0.001 
Questionnaire        
“How much do you 
like salty food?” 
7 (5.5–
7.5) 
6 (5–8) 5 (3–8) 1.000 0.400 0.352 0.419 
“How often do you 
add more salt to 
your food” 
3.5 (2–
6.5) 
3(1–5) 2 (1–3) 0.497 0.059 0.504 0.129 
“How much do you 
like salty snacks such 
as crisps?” 
8 (5.5–8) 5 (4–7) 7 (4–9) 0.242 0.916 0.552 0.379 
“How often do you 
eat in fast food 
restaurants?” 
4 (2.5–
4.5) 
4 (3–5) 3 (2–4) 1.000 0.088 0.126 0.124 
“How much money 
do you usually 
spend there?” (€) 
5 (2.8–8) 9 (5–10) 5 (4–9.5) 0.197 1.000 0.161 0.218 
“How often do you 
drink beverages 
without additional 
flavour?” 
7 (5–9.5) 10 (9–10) 10 (8–10) 0.166 0.058 1.000 0.122 
“How much do you 
drink daily?” (L) 
1.5 (1.1–
2) 
1.5 (1–2.5) 2 (1–2.3) 0.601 0.524 1.000 0.587 
Questionnaire on a scale from 1–10 (1 = I strongly agree; 10 = I strongly disagree) unless stated otherwise. 
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Figure 1. Group characteristics. (a) Boxplots of body-mass index (BMI) of controls, normotensive 
obese and hypertensive obese (b) Boxplots of heart rate of controls, normotensive obese and 
hypertensive obese (c) Boxplots of systolic blood pressure of controls, normotensive obese and 
hypertensive obese (d) Boxplots of diastolic blood pressure of controls, normotensive obese and 
hypertensive obese. Tests were performed using a Kruskal–Wallis Test (N = 32) with inter-group 
p-values according to Bonferroni corrected Dunn’s test. *p-value <0.05 compared to controls #p-value 
<0.05 compared to normotensive obese. 1diastolic hypertension (above the 95th percentile). 
3.1. Tissue Na+, Water and Fat Content 
We found significant differences in tibial bone Na+ content, subcutaneous fat Na+ content and 
water content of muscle, skin, tibial bone and subcutaneous fat in none of the groups 
(Supplementary Figure 1). 
Muscle Na+ content did not differ (p = 1.00) between controls (15.37 mmol/L [interquartile range 
14.12–16.08]) and normotensive obese (13.63 mmol/L [12.97–17.64]), but was significantly lower than 
both of these groups (p = 0.012 and p = 0.043, respectively) in hypertensive obese (11.95 mmol/L 
[11.62–13.66]) (Figure 2a). The Bland–Altman plot showed only low inter-observer variability in 
muscle Na+ content, due to variations in data processing (Supplementary Figure 2). 
  
J. Clin. Med. 2019, 8, 2036 6 of 13 
 
 
Figure 2. Na+ content in different tissues (a) Boxplots of triceps surae muscle Na+ of controls, 
normotensive obese and hypertensive obese (b) Boxplots of skin Na+ content of controls, 
normotensive obese and hypertensive obese. Tests were performed using a Kruskal–Wallis Test (N = 
32) with inter-group p-values according to Bonferroni corrected Dunn’s test. *p-value <0.05 compared 
to controls #p-value <0.05 compared to normotensive obese. 1diastolic hypertension (above the 95th 
percentile) (c) The scatter plot and the linear regression model show an inverse correlation between 
triceps surae Na+ content and systolic blood pressure (p = 0.0025, R2 = 0.27, N = 32) (d) Scatter plot and 
the linear regression model, showing no significant correlation between skin Na+ content and systolic 
blood pressure (p = 0.1060 R2 = 0.09). 
In contrast, skin Na+ content in normotensive obese (14.12 mmol/L [13.15–15.83]) was 
significantly higher (p = 0.004) than in controls (11.48 mmol/L [10.48–12.80]), while it tended to be 
higher in hypertensive obese (13.33 mmol/L [11.53–14.22]; p = 0.144). There was no difference 
between obese adolescents with or without hypertension (p = 0.237) (Figure 2b). 
Cross-sectional total Na+ content of all compartments in hypertensive obese was 12.01 mmol/L 
[11.41–12.89] and was significantly lower than in normotensive obese (p = 0.045) and controls (p = 
0.005). Total Na+ content did not significantly differ between controls (15.15 mmol/L [12.70–15.69]) 
and normotensive obese (13.02 mmol/L [12.39–14.98]; p = 0.866). 
The proportion of fat tissue within the muscle did not vary between all three groups. No 
significant correlation was found (p = 0.149, R2 = 0.037) between the amount (area) of fat tissue and 
muscle sodium content (Table 1). 
3.2. Na+ Content and Arterial Hypertension 
As recent studies have reported correlations between Na+ accumulation and hypertension in 
adults [9], we further investigated these aspects in an adolescent cohort: an inverse correlation was 
found between muscle Na+ content and systolic blood pressure (p = 0.0025; R2 = 0.27; Figure 2c) and 
cross-sectional total sodium content (p=0.0173, R2=0.12). These effects were not attributed to BMI. In 
obese patients, no significant correlations were found between BMI and muscle Na+ content and total 
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cross-sectional Na+ content. No significant correlation was found between skin Na+ content and 
systolic blood pressure (Figure 2d). 
Since a relationship between arterial hypertension and heart rate increase was described in the 
literature for obesity, heart rates were also compared between groups2. The heart rate in 
hypertensive obese (84 [72–87]) was significantly higher (p = 0.008 and p = 0.025, respectively) than in 
controls (69 [64–74]) and normotensive obese (68 [60–76]). Between controls and normotensive 
obese, heart rate did not differ (p = 0.386, Figure 1b). 
A logistic regression model (Figure 3) in obese showed that the probability of hypertension was 
significantly associated with lower muscle Na+ content (p = 0.038). The risk for hypertension and its 
uncertainty is also shown in the figure, and was increased to >80% in patients with triceps surae 
muscle Na+ content below 12 mmol/L. 
 
Figure 3: Logistic model showing the probability of hypertension according to muscle Na+ content 
with 95% confidence intervals (CI). (p = 0.038; N = 32) 
3.3. Sex Differences in Na+ Content and Arterial Hypertension 
Sex differences were assessed for all storage compartments. No significant sex-specific 
differences were found for muscle Na+ content. Additionally, the associations between arterial 
hypertension and muscle sodium content, as well as total sodium content, were independent of the 
patient’s sex. Robust linear regression demonstrated associations (p <0.001; R2 = 0.40) between skin 
Na+ content and independent variables of (1) female sex (Coef. -1.31 95% CI -2.52 to -0.10, p = 0.034) 
and (2) being normotensive obese (Coef. 2.69 95% CI 1.20 to 4.19, p = 0.001) but not (3) being 
hypertensive obese (p = 0.201). Tibial bone Na+ content was significantly lower in obese females (4.71 
mmol/L [1.38–6.63]) than in obese males (7.45 mmol/L [6.10–9.14]; p = 0.025). Robust linear regression 
showed an association (p = 0.023; R2 = 0.25) between tibial bone Na+ content and independent 
variables of (1) female sex (Coef. -3.20, 95% CI -5.85 to -0.55, p = 0.020), but not (2) being hypertensive 
obese (p = 0.624) or (3) normotensive obese (p = 0.389). In other compartments, we did not find 
sex-specific differences in Na+ content. 
3.4. Salt Intake, Tissue Na+ and Glucose Metabolism 
The responses to the questionnaire items in all groups are shown in Table 1. In all items, no 
differences were found between groups regarding salt appetite or salty fast food craving. 
Hyperinsulinism, reflected by a HOMA index of 2.0 or higher, was found in 87% of all obese 
patients. We found a weak correlation between HbA1c and systolic blood pressure (p = 0.088; R2 = 
0.18 n = 19; Figure 4a), but a stronger one between Na+ content of the whole leg and blood glucose 
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levels after 1 h (p = 0.034; R2 = 0.63; n = 11; Figure 4b) and 2 h of OGTT (p = 0.084; R2 = 0.56; n = 11; 
Figure 4c). These effects were not found in other tissue compartments. 
 
 
Figure 4: Tissue Na+ and glucose metabolism. (a) Linear regression model with 95% CI combined 
with scatter plot, showing no significant correlation between HbA1c and systolic blood pressure (n = 
19). (b) Linear regression model with 95% CI, combined with scatter plot showing a significant 
correlation between Na+ of the whole leg and blood glucose 1 h after an oral glucose tolerance test 
(OGTT, p = 0.0034 R2 = 0.63, n = 11). (c) The linear regression model with 95% CI, combined with 
scatter plot showing a significant correlation between Na+ of the whole leg and blood glucose 2 h 
after an OGTT (p = 0.0084 R2 = 0.56, n = 11). 
3.5. Power Calculation 
A power calculation using a Satterthwaite’s t-test for unequal variances, based on relevant 
differences in muscle sodium content, and a group A (hypertensive obese) mean of 12.8 ± 1.877 and a 
group B (control) mean of 15.248 ± 1.657 mmol/L, a total sample size of N = 23 for both groups and a 
level of significance of 5% (two-sided), resulted in an estimated power of 92%. To estimate statistical 
power of differences between normotensive and hypertensive obese, a Group A (normotensive 
obese) mean of 14.9 ± 2.6190 and a Group B (control) mean of 15.248 ± 1.657 mmol/L, a total sample 
size of N = 20 for both groups and a level of significance of 5% (two-sided) resulted in an estimated 
power of 57%. 
4. Discussion 
Little progress has been made in preventing the emergence of cardiovascular risk factors, such 
as obesity and hypertension in their early stages [1,20]. The pathophysiological link between these 
conditions and the role of mineral Na+ intake remains incompletely understood, hampering the 
development of targeted prevention measures. In previous studies, tissue Na+ accumulation has 
been proposed as a factor in the pathogenesis of hypertension, based on findings of raised tissue Na+ 
in hypertensive adults [9], but its association with blood pressure status in childhood has not been 
studied before. We found that obese adolescents with hypertension had lower triceps surae muscle 
Na+ and lower total cross-sectional Na+ content than those without hypertension or normotensive 
controls. These effects were independent of the patients’ BMI. When comparing our results with 
those of hypertensive adults, one must be aware that these studies, to our knowledge, do not 
consistently provide information on patients’ weight [9]. Future studies should, therefore, further 
investigate to what extent tissue sodium storage in hypertensive and normotensive adults is linked 
to mechanisms of ageing and obesity. 
4.1. Tissue Na+ Contents in Adults 
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23Na-MRI has been established as a non-invasive method for the quantification of Na+ content in 
different tissues[9–13,21]. Although our picture of Na+ homeostasis and tissue storage is still 
fragmented, this novel approach has made it possible to gain a considerable amount of knowledge in 
recent years. Tissue Na+ content was previously found to be elevated, among others, in patients with 
lipoedema [22], acute heart failure [11] or acute kidney disease [12] and chronic kidney disease [13]. 
In patients with refractory hypertension, women showed increased skin Na+ content compared to 
controls, whereas men showed higher muscle Na+ content compared to controls [9]. Increasing age 
further intensifies these differences in compartment distribution [17]. Additionally, sex differences 
have been described in a recent study [17]. In our study, we found higher skin and tibial bone Na+ 
content in males. Although these findings are in line with previous studies for the skin, the tibial 
bone has not yet been described as a compartment for sodium storage/depletion in patients with 
normal renal function, as its overall sodium content is typically much lower than that in the 
muscle/skin. 
4.2. Na+ and Blood Pressure 
The World Health Organization (WHO) recommends less than 2 g/day Na+ in adults, and even 
lower doses in children [23]. As the actual mean daily intake of Na+ is as high as 3.6 g/day in the US, 
UK, and Germany, we presume high salt intake also plays an important role in our study cohort [5]. 
Using questionnaires to semi-quantify the “salt appetite” of our participants, we did not observe any 
differences between the groups. However, to record the actual salt intake, complex measurements of 
nutritional composition would be required. 
Salt-loading studies with salt-resistant subjects have shown that, during acute or chronic 
salt-loading, normotensive salt-resistant subjects do not excrete Na+ faster, nor do they experience 
more blood volume expansion. Instead, they substantially retain Na+ in a rhythmical manner, which 
is in line with our concept of relevant tissue Na+ buffers [24,25]. Impairment of these buffer 
mechanisms in our “early disease stage” study could be an important contributor to the onset of 
arterial hypertension: while, in obese young patients without hypertension, Na+ storage in the 
muscle (the largest previously described buffer compartment) is only slightly reduced, in those with 
hypertension we observed an accentuated reduction of Na+ storage in muscle. In other 
compartments, such as the skin, tibial bone and subcutaneous fat, Na+ did not show significant 
differences in hypertensive obese, excluding a potential Na+ shift to those compartments nearby. 
Previous studies observed salt-sensitivity in some individuals, which describes an increase in 
blood pressure as a response to increases in dietary Na+ intake and vice versa [20,25,26]. In this 
context, the RAAS seems to be an important factor: it controls the vascular tone and—through Na+ 
reabsorption—the intravascular volume homeostasis, as well as the heart rate, through Angiotensin 
II activation [2,27]. Presuming similar Na+ intake in all groups, without a significant shift to other 
compartments, impaired muscle Na+ storage in hypertensive obese can result in elevated Na+ 
excretion through two major mechanisms: 1) altered RAAS suppression [28] and 2) pressure 
natriuresis as a regulatory response mechanism in salt-sensitive hypertensive subjects [29] through 
hypertension itself. Elevated heart rates in our cohort of hypertensive obese are in line with an 
overactivation of the sympathetic nervous system that has been described as an essential factor in 
the pathogenesis of obesity-induced hypertension in rabbits, dogs and humans [2]. 
In adults with long-term hypertension, recent reports suggest osmotically inactive Na+ storage 
in the skin via negatively charged glycosaminoglycans as binding partners [18]. We found elevated 
skin Na+ content in normotensive obese compared to normal-weight controls. However, these effects 
were not found in hypertensive obese. Therefore, no such conclusions can be made for skin Na+ 
content in adolescents. 
Before Na+ transfers from the vascular system to tissue, there are two barriers to overcome: the 
negatively charged endothelial glycocalyx layer and the endothelial Na+ channel ENaC [30]. 
Therefore, Na+ homeostasis and salt sensitivity in arterial hypertension might be associated not only 
with a subnormal ability to excrete sodium load, but also with vascular endothelial dysfunction 
[24,27]. Whereas in patients with different stages of chronic kidney disease, salt restriction can 
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reduce blood pressure [31], no controlled studies have been performed to demonstrate that 
hypertensive subjects excrete sodium more slowly and retain more of it than normotensive subjects. 
One could, therefore, speculate whether regulatory mechanisms in adolescents are different 
from those observed in older patients. If the muscle, as a main Na+ storage compartment, stores less, 
maintenance of blood sodium homeostasis will depend more on excretion and other storage 
compartments. This may reflect a compensatory mechanism at an early stage of the 
disease-preventing tissue Na+ overload, and further research will be needed to investigate the 
hormonal cascades involved, as well as absolute Na+ excretion, as plasma Na+ needs to maintain 
stable. 
4.3. Na+ Homeostasis and Hyperinsulinism 
Insulin alone has long been thought to cause Na+ retention, with enough effects to contribute to 
arterial hypertension [32,33]. A study by Brands and colleagues showed that such Na+-retaining 
effects may be limited to uncontrolled Type II diabetes [32]. In 11 maintenance haemodialysis 
patients, higher muscle sodium content was, in a similar way, associated with insulin resistance [34]. 
Furthermore, in the soleus muscle of salt-sensitive hypertensive Dahl rats, the RAAS was shown to 
activate the NF-κB pro-inflammatory pathway, inducing moderate hyperinsulinemia and insulin 
resistance [33]. A recent study also demonstrated a positive statistical correlation between Na+ intake 
and insulin resistance in obese children and adolescents [35]. A majority (87.5%) of our disease 
cohort not only had hyperinsulinism, but were also showing a trend between HbA1c and blood 
pressure, even at this early stage of the disease. 
Although the relation between obesity and hyper-caloric diets is known, the association 
between obesity and Na+ still remains unclear, as the quantification of salt intake is measured highly 
subjectively, through questionnaires or food records, unless investigators have the unusual 
opportunity of controlling their subjects’ nutrition completely, as done by Titze et al. in their space 
flight simulations [25]. In our study, we used salt questionnaires to assess the habits of salt intake 
and did not note any elevation of salt consumption or salty fast food craving in hypertensive or 
normotensive obese compared to our controls. 
4.4.23. Na-MRI 
Due to its non-invasive nature, 23Na-MRI is increasingly used in clinical research projects, even 
though it requires the use of specific non-proton coils and yields a certain complexity in image 
acquisition and post-processing [8–13,21]. 
Our study was performed at a 3 Tesla clinical scanner with a previously described 
measurement set-up [9,10]. A calibration curve using aqueous reference saline solutions was 
generated alongside to all scans, and 196 signal averages were applied to improve image 
homogeneity. We also determined intra- and inter-observer variability that did not show any 
significant differences between measurements. Compartments were assessed separately, as the 
total-cross-sectional Na+ content (shown for completeness) can be prone to averaging artefacts when 
different tissue types are combined, and the effects of the largest storage compartments (the muscle) 
may dominate. 
4.5. Limitations 
Within this study, we did not perform interventions such as salt loading tests, and, furthermore, 
assessments of the RAAS and Na+ excretion were not part of the study protocol. As indicated by our 
findings, future prospective and longitudinal studies should further evaluate the impact of such 
interventions and assess the complex interplay of hormonal axes (including the RAAS), as well as 
their linkage to the inflammation and glucose/insulin metabolism, as this may be of high relevance 
in future treatment-planning strategies. Furthermore, and as already stated above, salt intake was 
not measured quantitatively. 
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Statistical power to assess differences in muscle sodium content between controls and 
hypertensive obese was 92%, however, it was 57% for differences between controls and 
normotensive obese, due to sample size and the large heterogeneity within normotensive obese. 
These findings may be of use for future study planning. 
5. Clinical Outlook and Conclusions 
In obese adolescents with hyperinsulinism, arterial hypertension occurs in the presence of low 
muscle tissue Na+ content, independent of the patient’s BMI. These findings suggest a different 
regulation of muscle Na+ homeostasis and storage in early-onset obesity for hypertension compared 
to normotensive patients, adding a new perspective to salt-induced hypertension and salt 
sensitivity, if main storage compartments store less. The role of Na+ storage, salt sensitivity and 
insulin resistance in the initial stages of arterial hypertension, and the extent of the compensatory 
mechanisms that can become maladaptive at a later stage of the disease, as well as differences to 
isolated arterial hypertension in adults, remain to be further investigated in future clinical research. 
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